InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
Kobe Ginobili Free
09/23/12 3:49 PM
profile icon
Wildbilly Free
05/09/12 12:07 PM
profile icon
Wildbilly Free
02/28/11 3:51 PM
profile icon
SSP Grandfathered
11/09/09 3:06 PM
profile icon
SSP Grandfathered
06/12/09 10:45 AM
profile icon
Wildbilly Free
05/28/09 4:11 PM
profile icon
SSP Grandfathered
05/28/09 3:32 PM
profile icon
SSP Grandfathered
02/01/09 11:30 PM
profile icon
SSP Grandfathered
01/30/09 12:33 PM
profile icon
EdF Grandfathered
01/11/09 12:52 PM
profile icon
SSP Grandfathered
01/09/09 11:47 AM
profile icon
EdF Grandfathered
01/09/09 9:21 AM
profile icon
SSP Grandfathered
10/03/08 3:10 PM
profile icon
SSP Grandfathered
09/03/08 4:55 PM
profile icon
jwalk PremiumMember
09/03/08 4:02 PM
profile icon
SSP Grandfathered
08/08/08 2:21 PM
profile icon
MWM Free
08/08/08 2:15 PM
profile icon
SSP Grandfathered
08/08/08 1:37 PM
profile icon
SSP Grandfathered
06/17/08 2:20 PM
profile icon
EdF Grandfathered
06/17/08 2:19 PM
profile icon
SSP Grandfathered
06/17/08 1:54 PM
profile icon
trek925 Free
06/17/08 1:47 PM
profile icon
SSP Grandfathered
06/17/08 12:46 PM
profile icon
chrisfromalbany Free
06/17/08 8:27 AM
profile icon
SSP Grandfathered
06/16/08 11:57 PM
profile icon
MWM Free
06/16/08 11:55 PM
profile icon
MWM Free
06/16/08 11:50 PM
profile icon
MWM Free
06/16/08 11:50 PM
profile icon
MWM Free
06/16/08 11:49 PM
profile icon
MWM Free
06/16/08 11:49 PM
profile icon
SSP Grandfathered
06/16/08 11:36 PM
profile icon
SSP Grandfathered
06/16/08 11:25 PM
profile icon
SSP Grandfathered
06/16/08 11:15 PM
profile icon
MWM Free
06/06/08 9:07 AM
profile icon
chrisfromalbany Free
06/03/08 3:36 PM
profile icon
SSP Grandfathered
06/03/08 1:32 PM
profile icon
MWM Free
06/03/08 1:30 PM
profile icon
SSP Grandfathered
06/03/08 1:28 PM
profile icon
MWM Free
06/03/08 1:26 PM

Pilot Therapeutics Holdings, Inc. (PLTT) RSS Feed

Followers
11
Posters
54
Posts (Today)
0
Posts (Total)
724
Created
11/14/06
Type
Free
Moderators
Pilot Therapeutics Holdings, Inc. (OTC Bulletin Board: PLTT), a specialty pharmaceutical company developing and commercializing a portfolio of pharmaceutical and clinically validated over-the-counter (OTC) products http://www.pilottherapeutics.com/ Share Structure Info: 11.554M OS 2.674M Float Pilot has licensed / partnered with Efficas, Inc. http://www.pilottherapeutics.com/12.html http://www.efficas.com/ In 2002, Pilot's Airozin asthma medication had already gone through 5 clinical trials and was scheduled for a commercial launch later in the year. Back then, Pilot was making a lot of waves...being fought over by 2 states, NC and SC. The tug of war landed the co. in SC, as the co. was lured to move there on $17M of incentives. NC couldn't compete w/ the offer. Unfortunately, the funds never materialized, and rather than play it stupid and dillute the co. to death, knowing of their prized intellectual property, they chose to close their doors in pursuit of other avenues, such as partnering up w/ someone else. That someone else is Efficas...who is already selling 3 product lines based on Pilot's formula. Pilot just recently moved back to NC...but during it's stay in SC, brought on Scott Derks -- Marketing Director For SC Department Of Commerce -- who is now serving as Pilot's President. Executive Leadership Team Ross Consaul , CEO. http://center.spoke.com/info/p6ElmTG/RossConsaul As CEO of Pilot, Ross brings over 20 years experience leading R&D, New Product Development and New Ventures for large and small companies including Bayer, Kellogg, Pizza Hut and Kashi. Skilled at matching technology possibilities with market needs he has created and launched new products and businesses with total annual sales of $2 billion across multiple categories, brands and channels. He has also been instrumental in identifying, acquiring and integrating new businesses with combined annual sales of $3 billion. Ross was most recently Nutrition General Manager, Bayer BioScience, where he was responsible for identifying and creating new businesses in health and nutrition for the $38 billion Bayer Company. In this role, he identified and developed comprehensive business plans for new opportunities with combined annual revenue projections in excess of $1.5 billion. Before joining Bayer, Ross was Head of Innovation in the Research Quality and Technology group at the $9 billion Kellogg Company, accountable for developing new product and business opportunities and leading technology discovery. Keith Wakeman, President. As President of Pilot, Keith brings over 20 years food and nutrition industry experience leading marketing, innovation, and new ventures organizations across a broad range of categories and brands. Keith was head of Innovation for the $2 billion Kellogg’s Snacks Division and led New Ventures for both the $9 billion Kellogg Company and the $2 billion Keebler Company. He also led brand teams and held various trade marketing and sales roles at Nabisco, Leaf and Procter & Gamble. Keith has developed and launched new products generating nearly $1 billion revenue. Prior to joining Pilot, Keith was President of Cherry Street Innovation LLC, an innovation company he founded to identify and develop new growth platforms through new ventures and brand innovation. Through his leadership, CSI identified opportunities and developed business plans for new ventures projected to generate nearly $2 billion annual revenue. Keith serves on the Boards of several entrepreneurial companies including a start-up branded organic beef business and big Boing, a product innovation and brand launch company. Ski Chilton, Chief Technology Officer. Dr. Chilton is widely recognized in academia and industry for his work on the role of fatty acid metabolism in human diseases. He has extensive experience in leading organizations in both of these areas. Dr. Chilton is currently a Full Professor in the Department of Physiology and Pharmacology and Director of the Wake Forest and Brigham and Women’s Center for Botanical Lipids at Wake Forest University Health Sciences. Dr. Chilton also founded the Program in Molecular Medicine at Wake Forest University Health Sciences and helped build it into one of the most successful Programs of its kind in the United States. During his time in academia, Dr. Chilton has served as Director of Molecular Medicine, Professor of Physiology and Pharmacology, Professor of Internal Medicine and Professor of Biochemistry at the Wake Forest University as well as Assistant Professor of Internal Medicine at the Johns Hopkins School of Medicine. He also served as Associate Director of the Asthma and Airways Diseases Center and Associate Director of Programs in Clinical Research at Wake Forest University Health Sciences. Dr. Chilton has served as Chairman and has organized several international meetings on dietary regulation of human disease and lipid metabolism. Dr Chilton has authored or co-authored over 110 scientific articles and book chapters. He holds 32 issued and 17 pending patents. In 2005, Dr. Chilton wrote a book, Inflammation Nation, which was published by Simon and Schuster. In 2006, he wrote Win the War Within, which was published by Rodale. Dr. Chilton obtained his Ph.D. in Biochemistry from Wake Forest University in 1984. He served as a Postdoctoral Fellow in Pharmacology at the University of Colorado until 1986. He has received numerous awards in his career including the Cowgill Scholar Award at Wake Forest, the Sigma Xi Research Award at Wake Forest, the 1999 Distinguished Academic and Achievement Award from Western Carolina University and The Distinguished Service and Teaching Award from the Italian Congress on Allergy and Immunology. Scott Derks, Chief Operations Officer. Scott combines the practical skills of a veteran banker with the creative drive of an award winning writer who has authored 14 books. He spent 20 years managing cultural change, profitability and merger activity during the consolidation of the banking industry in the 1980s and 1990s. During his last three years in banking, he served as a Senior executive with Bank of America and Chief of Staff to the company's flagship North Carolina and South Carolina operation. For the past two years he has orchestrated the renaissance of Pilot Therapeutics from dormancy to re-launch first as a consultant, then as president. During that time he has focused on establishing a commercial foundation for Pilot in partnership with Wake Forest Medical University. Scott’s most recent book is Working Americans: Social Movements 1880-2006, his seventh book in the series. He also serves on the board of CIVISonLine, an internet company working with the BBC, New York Times and Yahoo to create the ‘global conversation.”
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
PLTT Latest News
  • No Recent News Available for this company!
New Post